Featured Research

from universities, journals, and other organizations

Anti-HBe May Play A Role In The Progression Of The Disease Of Hepatitis B

Date:
April 30, 2008
Source:
World Journal of Gastroenterology
Summary:
Researchers have determined that HBV genotype D is the dominant genotype in different clinical forms of either acute or chronic hepatitis. It has been determined that there is a significant association between the presence of anti-HBe antibody and increasing ALT levels among either HBeAg-negative or HBeAg-positive individuals. These results suggest that anti-HBe may play a role in the progression of the disease.

A team led by Dr. A Behzad-Behbahani from Shiraz University of Medical Sciences has determined that HBV genotype D is the dominant genotype in different clinical forms of either acute or chronic hepatitis. It has been determined that there is a significant association between the presence of anti-HBe antibody and increasing ALT levels among either HBeAg-negative or HBeAg-positive individuals. These results suggest that anti-HBe may play a role in the progression of the disease.

Related Articles


Genotype D is found to be the only detected type in different clinical forms of HBV infections, including cirrhosis, among residents of southwestern Iran. A significant association between the presence of anti-HBe antibody and increasing ALT levels among either HBeAg-negative or HBeAg-positive individuals was also determined.

The heterogeneity in the global distribution of HBV genotypes may account for differences in the clinical outcomes of HBV infections and in the responses to antiviral treatment. The clinical and serological statuses of the patients infected with a specific genotype of HBV in this geographic region (southwestern Iran) need to be further investigated.

Serum samples were collected from HBsAg-positive subjects attending the Gastroenterology and Hepatology Clinic at the Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, in southwestern Iran. The definition and diagnostic criteria for clinical terms were adopted from the American Association for the Study of Liver Disease (AASLD) practice guidelines. All sera were then investigated to determine HBV DNA and serological markers. For all the positive quantitative PCR samples, biochemical and histopathological assays and genotyping were also performed. Quantitative real-time PCR assays were carried out using SYBER-Green signal detection. Abdominal ultrasounds were also performed to determine if there were features of cirrhosis. Liver biopsies were performed based on clinical indications.

Genotype D was the only type detected in different clinical forms of acute and chronic infections. There was an increased prevalence of HBeAg-negative status among HBV-infected patients with chronic hepatitis. Cirrhosis was diagnosed among patients with chronic hepatitis. A significant association between the presence of anti-HBe antibody and the increase in ALT levels among either HBeAg-negative or HBeAg-positive individuals was demonstrated. No significant differences were observed between the clinical outcomes of HBeAg-positive and ¨Cnegative patients.

In the view of the authors, this report shows the prevalence of this specific genotype of HBV and its clinical relevance in a part of the Middle East. This isolated genotype is associated with active disease, cirrhosis and hepatocellular carcinoma. A significant number of patients infected with genotype D were HBeAg-negative. Another interesting finding was that a large number of patients with positive anti-HBe had elevated ALT levels.

Using a prospective cohort study in a group of patients infected with HBV genotype D would be helpful to assess the clinical outcomes of different management strategies for the patients. An in vitro study needs to be established in order to clarify the molecular biology of different HBV genotypes.

Further research should explain the mechanism of pathogenesis of different HBV genotypes in specific geographical regions.

Reference: Mojiri A, Behzad-Behbahani A, Saberifirozi M, Ardabili M, Beheshti M, Rahsaz M, Banihashemi M, Azarpira N, Geramizadeh B, Khadang B, Moaddeb A, Ghaedi M, Heidari T, Torab A, Salah AR, Amirzadeh S, Jowkar Z, Mehrabani D, Amini-Bavil-Olyaee S, Dehyadegari MA. Hepatitis B virus genotypes in southwest Iran: Molecular, serological and clinical outcomes. World J Gastroenterol 2008; 14(10): 1510-1513

http://www.wjgnet.com/1007-9327/14/1510.asp


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Cite This Page:

World Journal of Gastroenterology. "Anti-HBe May Play A Role In The Progression Of The Disease Of Hepatitis B." ScienceDaily. ScienceDaily, 30 April 2008. <www.sciencedaily.com/releases/2008/04/080430091755.htm>.
World Journal of Gastroenterology. (2008, April 30). Anti-HBe May Play A Role In The Progression Of The Disease Of Hepatitis B. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2008/04/080430091755.htm
World Journal of Gastroenterology. "Anti-HBe May Play A Role In The Progression Of The Disease Of Hepatitis B." ScienceDaily. www.sciencedaily.com/releases/2008/04/080430091755.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins